Properties of low density lipoproteins relevant to oxidative modifications change paradoxically during aging

Atherosclerosis

Volumn 126, Issue 1, 1996, Pages 85-94

  Stulnig, Thomas M ^a   Jürgens, Günther ^b   Chen, Qi ^b   Moll, Denise ^c   Schönitzer, Dieter ^d   Jarosch, Elmar ^d   Wick, Georg ^a,e  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^e ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

Aging; Anti oxidants; Atherosclerosis; Lipid peroxidation; Low density lipoproteins (LDL); Polyunsaturated fatty acids; SENIEUR protocol

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; LOW DENSITY LIPOPROTEIN; TOCOPHEROL;

ADULT; AGED; AGING; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DIET; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; LIPID ANALYSIS; LIPID METABOLISM; LIPID PEROXIDATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030603985     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05896-0     Document Type: Article

References (45)

1. [1] Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915.
2. [2] Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989;86:1372.
3. [3] Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785.
4. [4] Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801.
5. [5] Andrews B, Burnand K, Paganga G, Browse N, Rice-Evans C, Sommerville K, Leake D, Taub N. Oxidizability of low density lipoproteins in patients with carotid or femoral artery atherosclerosis. Atherosclerosis 1995;112:77.
6. [6] Esterbauer H, Gebicki J, Puhl H, Jürgens G. The role of lipid peroxidation and anti-oxidants in oxidative modification of LDL. Free Radical Biol Med 1992;13:341.
7. [7] Henricksen T, Mahoney TM, Steinberg D. Enhanced macrophage degradation of biologically modified low-density lipoprotein. Arteriosclerosis 1983;3:149.
8. [8] Morel DW, Hessler JR, Chrisolm GM. Low density lipoprotein cytotoxicity induced by free radical peroxidation. J Lipid Res 1983;24:1070.
9. [9] Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/ macrophages during atherogenesis. Proc Natl Acad Sci USA 1987;84:2995.
10. [10] Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086.
11. [11] Jürgens G, Chen Qi, Esterbauer H, Mair S, Ledinski G, Dinges HP. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a). Arterioscler Thromb 1993;13:1689.
12. [12] Harman D. The aging process. Proc Natl Acad Sci USA 1981;78:7124.
13. [13] Penn MS, Chisolm GM. Oxidized lipoproteins, altered cell function and atherosclerosis. Atherosclerosis 1994;108:S21.
14. [14] Ligthart GJ, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kennes B, Müller-Hermelink HK, Steinmann GG. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev 1984;28:47.
15. [15] Traill KN, Schönitzer D, Jürgens G, Böck G, Pfeilschifter R, Hilchenbach M, Holasek A, Förster O, Wick G. Age related changes in lymphocyte subset proportions, surface differentiation antigen density and plasma membrane fluidity: application of the EURAGE SENIEUR protocol admission criteria. Mech Ageing Dev 1985;33:39.
16. [16] Reibnegger G, Huber LA, Jürgens G, Schönitzer D, Werner ER, Wachter H, Wick G, Traill KN. Approach to define 'normal aging' in man, immune function, serum lipids, lipoproteins and neopterin levels. Mech Ageing Dev 1988;46:67.
17. [17] Stulnig T, Mair A, Jarosch E, Schober M, Schönitzer D, Wick G, Huber LA. Estimation of reference intervals from a SENIEUR protocol compatible aged population for immunogerontological studies. Mech Ageing Dev 1993;68:105.
18. [18] Vuilleumier JP, Keck E. Fluorometric assay of vitamin C in biological materials using a centrifugal analyser with fluorescence attachment. J. Micronutr Anal 1989;5:25.
19. [19] Hess D, Keller HE, Oberlin B, Bonfanti R, Schuep W. Simultaneous determination of retinol, tocopherols, carotenes and lycopene in plasma by means of high-performance liquid chromatography on reversed phase. Int J Vit Nutr Res 1990;61:232.
20. [20] Jürgens G, Ashy A, Esterbauer H. Detection of new epitopes formed upon oxidation of low-density lipoprotein, lipoprotein (a) and very-low-density lipoprotein. Biochem J 1990;265:605.
21. [21] Chen Q, Esterbauer H, Jürgens G. Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochem J 1992;288, 249:249.
22. [22] Himber J, Bühler E, Moll D, Moser UK. Low density lipoprotein for oxidation and metabolic studies. Isolation from small volumes of plasma using a tabletop ultracentrifuge. Int J Vit Nutr Res 1995;65:137.
23. [23] Chung BH, Segrest JP, Ray MJ, Brunzell JD, Hokanson JE, Krauss RM, Beaudrie K, Cone JT. Single vertical spin density gradient ultracentrifugation. Methods Enzymol 1986;128:181.
24. [24] Scheek LM, Wiseman SA, Tijburg LBM, van Tol A. Dialysis of isolated low density lipoprotein induces a loss of lipophilic anti-oxidants and increases the susceptibility to oxidation in vitro. Atherosclerosis 1995;117:139.
25. [25] Huber LA, Xu Q, Jürgens G, Böck G, Bühler E, Gey F, Schönitzer D, Traill KN, Wick G. Correlation of lymphocyte lipid composition, membrane microviscosity and mitogen response in the aged. Eur J Immunol 1991;21:2761.
26. [26] Thurnham D, Davies J, Crump B, Situnayake R, Davies M. The use of different lipids to express serum tocopherol: lipid ratios for the measurement of vitamin E status. Ann Clin Biochem 1986;23:514.
27. [27] Suematsu T, Kamada T, Abe H, Kikuchi S, Yagi K. Serum lipoperoxide level in patients suffering from liver diseases. Clin Chim Acta 1977;79:267.
28. [28] Hagihara M, Nishigaki I, Maseki M, Yagi K. Age-dependent changes in lipid peroxide levels in the lipoprotein fractions of human serum. J Gerontol 1984;39:269.
29. [29] Ericsson S, Eriksson M, Vitols S, Einarsson K, Berglund L, Angelin B. Influence of age on the metabolism of plasma low density lipoprotein in healthy males. J Clin Invest 1991;87:591.
30. [30] Harats D, Ben-Naim M, Dabach Y, Hollander G, Havivi E, Stein O, Stein Y. Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis 1990;85:47.
31. [31] Esterbauer H, Jürgens G. Mechanistic and genetic aspects of susceptibility of LDL to oxidation. Curr Opin Lipidol 1993;4:114.
32. [32] Jialal I, Norkus EP, Cristol L, Grundy SM. β-Carotene inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1991;1086:134.
33. [33] Princen HMG, Vanpoppel G, Vogelezang C, Buytenhek R, Kok FJ. Supplementation with vitamin-E but not β-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro - effect of cigarette smoking. Arterioscler Thromb 1992;12:554.
34. [34] Gaziano JM, Hatta A, Flynn M, Johnson EJ, Krinsky NI, Ridker PM, Hennekens CH, Frei B. Supplementation with β-carotene in vivo and in vitro does not inhibit low density lipoprotein oxidation. Atherosclerosis 1995;112:187.
35. [35] Maggi E, Chiesa R, Melissano G, Castellano R, Astore D, Grossi A, Finardi G, Bellomo G. LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers. Arterioscler Thromb 1994;14:1892.
36. [36] Tribble DL, van den Berg JJM, Motchnik PA, Ames BN, Lewis DM, Chait A, Krauss RM. Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and α-tocopherol content. Proc Natl Acad Sci USA 1994;91:1183.
37. [37] Parthasarathy S, Khoo JC, Miller E, Barnett J, Witztum JL, Steinberg D. Low density lipoprotein rich in oleic acid is proected against oxidative modification: implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci USA 1990;87:3894.
38. [38] Abbey M, Belling GB, Noakes M, Hirata F, Nestel PJ. Oxidation of low-density lipoproteins - intraindividual variability and the effect of dietary linoleate supplementation. Am J Clin Nutr 1993;57:391.
39. [39] Kleinveld HA, Hak-Lemmers HLM, Hectors MPC, de Fouw NJ, Demacker PNM, Stalenhoef AFH. Vitamin E and fatty acid intervention does not attenuate the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol 1995;15:290.
40. [40] Lecerf J, Rossignol A, Vericel E, Thies F, Farnier M, Lagarde M. Variations in the fatty acid composition of lipid classes from lipoproteins in elderly women. Atherosclerosis 1993;98:241.
41. [41] Schmuck A, Fuller CJ, Devaraj S, Jialal I. Effect of aging on susceptibility of low-density lipoproteins to oxidation. Clin Chem 1995;41:1628.
42. [42] Goldstein JL, Brown MS. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem 1977;46:897.
43. [43] Traill KN, Jürgens G, Böck G, Huber L, Schönitzer D, Widhalm K, Winter U, Wick G. Analysis of fluorescent low density lipoprotein uptake by lymphocytes. Paradoxical increase in the elderly. Mech Ageing Dev 1987;40:261.
44. [44] Traill KN, Huber LA, Wick G, Jürgens G. Lipoprotein interactions with T cells: an update. Immunol Today 1990;11:411.
45. [45] Stulnig TM, Klocker H, Harwood HJ jr, Jürgens G, Schönitzer D, Jarosch E, Huber LA, Amberger A, Wick G. In vivo low-density lipoprotein receptor and 3-hydroxy-3-methylgluatryl coenzyme A reductase regulation in human lymphocytes and its alterations during aging. Arterioscler Thromb Vasc Biol 1995;15:872.